ARTICLES BY LAURIE HALLORAN
-
Discovering & Motivating Talent In The Life Sciences: Redefining “Other Duties & Responsibilities”8/21/2020
How do we attract the right kind of talent to a role within our organizations? How do we take the same innovative approaches in our talent acquisition processes that we put into our products? One answer can be found in an often-overlooked bullet point in a common job description: “other duties and responsibilities as required.”
-
Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits3/19/2020
While we have not seen any significant delays in regulatory approval of life science products to date, the impact of COVID-19 on regulatory interactions, inspections, audits, and global health authorities is continuing to evolve.
-
8 Significant Risks COVID-19 Poses To Clinical Trials — And How To Mitigate Them3/19/2020
The impact of COVID-19 on clinical trials has been immediate, due to challenges posed by travel bans, hospital/clinic visitation restrictions, and social distancing precautions, just to name a few. These factors have translated into multiple issues that pose challenges related to corporate milestones, budgets, and data integrity.